Tag: Lupin
Lupin Digital Health introduces comprehensive post-procedure home-based care guide
This guide is based on the American College of Cardiology (ACC)’s ‘Home-Based Care Workbook’ and has been developed by LDH along with the workgroup constituted by the ACC
BioVoice eMagazine January 2025 | Issue 1 | Volume 6
The Cover Story features flashback 2024 and a collective vision of industry leaders for 2025. Read interviews of Dr Abdelaziz Toumi, CEO, Lupin Manufacturing Solutions; and Dr Anil Gulati, Chairman and CEO, Pharmazz Inc. Expert Insights by Anindith Reddy, Managing Director, Enliva (Wadi Surgicals). Special Story on Agritech Startups.
Lupin Digital Health partners Medicover Hospitals for comprehensive post-discharge cardiac care
This groundbreaking partnership aims to reshape cardiac care in India, offering at-home rehabilitation, powered by digital therapeutics
Lupin’s R&D facility in Pune awarded LEED platinum certification
Amongst the first to be recognized for this distinguished milestone
Lupin’s ESG score rises to 76 in S&P Global ESG ratings
As per the company, a strong sustainability framework is at the heart of its strategy and the company has integrated it in all its business operations
Lupin strengthens presence in South Africa with acquisition of nine brands...
Pharma Dynamics expands product range in plant-based healthcare through deal with Medical Nutritional Institute
Lupin receives Health Canada approval for biosimilar Pegfilgrastim
This product will be marketed under the brand name Armlupeg® and manufactured at Lupin’s Biotech facility at Pune, India
Lupin’s revenue climbs 16.3% to INR 55,143 million in Q1 FY2025
Lupin Limited posts impressive gains with EBITDA rising by 48.9% and profit after tax nearly doubling compared to the previous year
Lupin completes Phase 3 trials for Lucentis Biosimilar
The successful completion of the global Phase 3 trials paves the way to obtain marketing approval in the U.S. and EU
Global biotech players repose faith in the India’s biosimilars growth story
The event organized by the International Contract Pharma Association (ICPA) in San Deigo witnessed deliberations on drug discovery services scenario in India